Pfizer (PFE)

Net Income Growth

-59.69%

TTM · Period ending:

PFE logo

PFE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-59.69%
PFE TTM Net Income YoY % (13.39% → -59.69%)
High-resolution chart · PNG

PFE net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
64.1154%
65.3781%
60.7738%
62.4694%
12.0956%
2.015%
-5.1328%
-12.7023%
43.6944%
50.8467%
51.4234%
51.6906%
19.1141%
14.3496%
14.7227%
17.599%
18.8759%
20.6349%
22.6397%
22.7206%
24.1615%
23.841%
21.1414%
19.3649%
100.2847%
92.8061%
97.4753%
227.147%
-21.4797%
-17.2348%
-18.9173%
-51.9503%
15.5326%
12.67%
12.2975%
-8.984%
-8.2998%
-8.1915%
-9.8727%
19.4274%
19.3444%
17.9861%
17.6332%
-0.2855%
-3.7012%
-14.7852%
-13.9265%
-6.4479%
-2.7009%
13.1337%
14.6479%
10.4354%
7.4701%
5.1091%
4.5758%
11.0938%
13.3914%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.